Viewing Study NCT02873195


Ignite Creation Date: 2025-12-24 @ 1:19 PM
Ignite Modification Date: 2026-02-11 @ 10:46 PM
Study NCT ID: NCT02873195
Status: COMPLETED
Last Update Posted: 2024-08-23
First Post: 2016-08-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer
Sponsor: Academic and Community Cancer Research United
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Colorectal Carcinoma View
None Recurrent Colorectal Carcinoma View
None Refractory Colorectal Carcinoma View
None Stage IV Colorectal Cancer AJCC v7 View
None Stage IVA Colorectal Cancer AJCC v7 View
None Stage IVB Colorectal Cancer AJCC v7 View
Keywords: